Identification of the Raf-1 signaling pathway used by camp to inhibit p42/p44 MAPK in rat lacrimal gland acini: Role in potentiation of protein secretion

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6321-6328

  Funaki, Chika ^a   Hodges, Robin R ^a   Dartt, Darlene A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CARBACHOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GGTI 298; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAF PROTEIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; LACRIMAL GLAND; LACRIMAL GLAND ACINI; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CARBACHOL; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC CMP; EPIDERMAL GROWTH FACTOR; ISOQUINOLINES; LACRIMAL APPARATUS; MALE; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SULFONAMIDES;

EID: 79955948886     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5690     Document Type: Article

References (32)

1. Dartt DA. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009;28(3): 155-177.
2. Lemullois M, Rossignol B, Mauduit P. Immunolocalization of myoepithelial cells in isolated acini of rat exorbital lacrimal gland: cellular distribution of muscarinic receptors. Biol Cell. 1996;86(2-3): 175-181.
3. Dartt DA, Dicker DM, Ronco LV, Kjeldsen IM, Hodges RR, Murphy SA. Lacrimal gland inositol trisphosphate isomer and inositol tetrakisphosphate production. Am J Physiol. 1990;259(2 pt 1): G274-G281.
4. Zoukhri D, Hodges RR, Willert S, Dartt DA. Immunolocalization of lacrimal gland PKC isoforms: effect of phorbol esters and cholinergic agonists on their cellular distribution. J Membr Biol. 1997; 157(2): 169-175.
5. Zoukhri D, Hodges RR, Sergheraert C, Toker A, Dartt DA. Lacrimal gland PKC isoforms are differentially involved in agonist-induced protein secretion. Am J Physiol. 1997;272(1 pt 1): C263-C269.
6. Hodges RR, Zoukhri D, Sergheraert C, Zieske JD, Dartt DA. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest Ophthalmol Vis Sci. 1997;38(3): 610-619.
7. Tepavcevic V, Hodges RR, Zoukhri D, Dartt DA. Signal transduction pathways used by EGF to stimulate protein secretion in rat lacrimal gland. Invest Ophthalmol Vis Sci. 2003;44(3):1075-1081.
8. Schmidt R, Baumann O, Walz B. Camp potentiates InsP3-induced Ca2[1] release from the endoplasmic reticulum in blowfly salivary glands. BMC Physiol. 2008; 8: 10.
9. Liu M, Simon MI. Regulation by Camp-dependent protein kinase of a G-protein-mediated phospholipase C. Nature. 1996;382(6586): 83-87.
10. Romano D, Magalon K, Ciampini A, Talet C, Enjalbert A, Gerard C. Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J Biol Chem. 2003; 278(51): 51386-51394.
11. Dartt DA, Baker AK, Vaillant C, Rose PE. Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am J Physiol. 1984;247(5 pt 1): G502-G509.
12. Funaki C, Hodges RR, Dartt DA. Role of cAMP inhibition of p44/ p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland. Am J Physiol Cell Physiol. 2007; 293(5): C1551-C1560.
13. Dartt DA, Baker AK, Rose PE, Murphy SA, Ronco LV, Unser MF. Role of cyclic AMP and Ca2[1] in potentiation of rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci. 1988;29(11): 1732-1738.
14. Dartt DA, Ronco LV, Murphy SA, Unser MF. Effect of phorbol esters on rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci. 1988;29(11): 1726-1731.
15. Ota I, Zoukhri D, Hodges RR, et al. Alpha 1-adrenergic and cholinergic agonists activate MAPK by separate mechanisms to inhibit secretion in lacrimal gland. Am J Physiol Cell Physiol. 2003; 284(1): C168-C178.
16. Hodges RR, Rios JD, Vrouvlianis J, Ota I, Zoukhri D, Dartt DA. Roles of protein kinase C, Ca2[1], Pyk2, and c-Src in agonist activation of rat lacrimal gland p42/p44 MAPK. Invest Ophthalmol Vis Sci. 2006; 47(8): 3352-3359.
17. Stork PJ. Does Rap1 deserve a bad Rap? Trends Biochem Sci. 2003;28(5):267-275.
18. Nagao S, Yamaguchi T, Kusaka M, et al. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int. 2003; 63(2): 427-437.
19. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Biol. 2005; 17(2): 123-128.
20. Hagiwara M, Alberts A, Brindle P, et al. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell. 1992;70(1):105-113.
21. Borland G, Smith BO, Yarwood SJ. EPAC proteins transducer diverse cellular actions of cAMP. Br J Pharmacol. 2009;158(1): 70-86.
22. Dartt DA. Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion. Exp Eye Res. 2004; 78(3): 337-345.
23. Gerits N, Kostenko S, Shiryaev A, Johannessen M, Moens U. Relations between the mitogen-activated protein kinase and the cAMPdependent protein kinase pathways: comradeship and hostility. Cell Signal. 2008;20(9): 1592-1607.
24. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 1993;262(5136): 1069-1072.
25. Chen C, Koh AJ, Datta NS, et al. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem. 2004;279(28): 29121-29129.
26. Edin ML, Juliano RL. Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor. Mol Cell Biol. 2005; 25(11): 4466-4475.
27. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12(6): 258-266.
28. Jarnaess E, Tasken K. Spatiotemporal control of cAMP signaling processes by anchored signalling complexes. Biochem Soc Trans. 2007;35(pt 5): 931-937.
29. Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005;437(7058): 574-578.
30. Fang Y, Olah ME. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther. 2007;322(3): 1189-2000.
31. Gao L, Feng Y, Bowers R, et al. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res. 2006;66(16): 7880-7888.
32. Enserink JM, Christensen AE, de Rooij J, et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol. 2002;4(11): 901-906.